InMed Pharmaceuticals’ Progress in Dry AMD Treatment with INM-089
The TDR Three Key Takeaways for InMed Pharmaceuticals Dry AMD: InMed Pharmaceuticals reports promising results with INM-089 for Dry AMD, suggesting a potential breakthrough in treatment. The new drug targets cannabinoid receptors, offering a novel approach …